Home/Filings/4/0001213900-25-069302
4//SEC Filing

Townsend John 4

Accession 0001213900-25-069302

CIK 0001766140other

Filed

Jul 29, 8:00 PM ET

Accepted

Jul 30, 4:30 PM ET

Size

5.3 KB

Accession

0001213900-25-069302

Insider Transaction Report

Form 4
Period: 2025-07-28
Townsend John
Chief Financial Officer
Transactions
  • Award

    Stock Options

    2025-07-28+10,000101,557 total
    Exercise: $4.71Exp: 2035-07-28Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]2,500 of the stock options vest on July 28, 2026 and 1/36th of the remaining options vest at the end of each successive month thereafter.

Documents

1 file

Issuer

Unicycive Therapeutics, Inc.

CIK 0001766140

Entity typeother

Related Parties

1
  • filerCIK 0001511906

Filing Metadata

Form type
4
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 4:30 PM ET
Size
5.3 KB